SCHEMBL363828

SCHEMBL363828

Cc1cc2c3ccccc3ncn2n1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 1.00
LMNA P02545 1/20 0.45
RAB9A P51151 2/20 0.39
NPC1 O15118 1/20 0.39
MAPK1 P28482 1/20 0.39
PDE10A Q9Y233 3/20 0.38
HSD17B10 Q99714 2/20 0.38
TSHR P16473 1/20 0.38
CYP1A2 P05177 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.37
TP53 P04637 1/20 0.37
ALDH1A1 P00352 1/20 0.36
HPGD P15428 1/20 0.36
CYP11B1 P15538 1/20 0.36
CYP11B2 P19099 1/20 0.36
NCF1 P14598 1/20 0.36
PARP1 P09874 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11472894 0.77 KDM4E (0.62) KDM4ELMNARAB9ANPC1HSD17B10
SCHEMBL11470591 0.74 KDM4E (0.59) KDM4ERAB9ANPC1HSD17B10TSHR
SCHEMBL29973757 0.73 KDM4E (0.57) KDM4ESMN1; SMN2
SCHEMBL29974345 0.71 KDM4E (0.54) KDM4ERAB9ANPC1MAPK1HSD17B10
SCHEMBL361719 0.71 KDM4E (0.54) KDM4ERAB9ANPC1MAPK1HSD17B10
SCHEMBL18922383 0.69 KDM4E (0.53) KDM4ELMNARAB9ANPC1MAPK1
SCHEMBL363209 0.69 NPC1 (0.56) KDM4ELMNARAB9ANPC1PDE10A
SCHEMBL3594951 0.68 KDM4E (0.51) KDM4ERAB9ANPC1MAPK1HSD17B10
SCHEMBL29967853 0.68 KDM4E (0.51) KDM4ERAB9ANPC1MAPK1HSD17B10
SCHEMBL10099710 0.67 PDE10A (0.50) KDM4ELMNARAB9APDE10AHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012007006-A1 TRIAZOLO- AND PYRAZOLOQUINAZOLINE DERIVATIVES AS PDE10A ENZYME INHIBITOR H. LUNDBECK A/S (DK) 2012-01-19 WO disclosed